why choose us

First received: March 24, 2023

Clinical Trial: Neural-net Artificial Pancreas (NAP)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type1 Diabetes

Study Type: INTERVENTIONAL


Official Title: Adaptive Motif-Based Control (AMBC): Pilot 1 - Neural Net Implementation of Automated Insulin Delivery

Brief Summary: This study is intended to assess a Neural-net Artificial Pancreas (NAP) implementation of an established AP controller - the University of Virginia Model Predictive Control Algorithm (UMPC).The health outcomes achieved on NAP will be compared to the health outcomes achieved on UMPC in a randomized crossover design.The investigators will consent up to 20 participants, ages ?18.0, with a goal of completing 15 participants.

Read more